Multicenter performance evaluation of the Alinity m CMV assay for quantifying cytomegalovirus DNA in plasma samples

Monitoring of cytomegalovirus (CMV) viral load is critical for informing treatment decisions in order to prevent the severe health consequences of CMV infection or reactivation of latent CMV in immunocompromised individuals. This first field evaluation examined the analytical and clinical performanc...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical microbiology 2023-10, Vol.61 (10), p.e0041523-e0041523
Main Authors:	Lee, Miae, Albert, Eliseo, Wessels, Els, Kim, Soo-Kyung, Chung, Hae-Sun, Giménez, Estela, Vreeswijk, Tom, Claas, Eric C J, Tai, Yan Chin, Reinhardt, Birgit, Sasaki, Mark M, Navarro, David
Format:	Article
Language:	eng
Subjects:	Cytomegalovirus - genetics Cytomegalovirus Infections - diagnosis DNA DNA, Viral - genetics Humans Immunocompromised Host Sensitivity and Specificity Viral Load
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Monitoring of cytomegalovirus (CMV) viral load is critical for informing treatment decisions in order to prevent the severe health consequences of CMV infection or reactivation of latent CMV in immunocompromised individuals. This first field evaluation examined the analytical and clinical performance of the Alinity m CMV assay. Analytical performance was assessed with a commercially available six-member panel, while the clinical performance evaluation compared the Alinity m CMV assay to the RealTi e CMV assay and a laboratory-developed test (LDT) as the test of record at three large hospital-based clinical laboratories. Precision of the Alinity m CMV assay was demonstrated with total standard deviation (SD) between 0.08 and 0.28 Log IU/mL. A total of 457 plasma specimens were tested on the Alinity m CMV assay and compared to the test of record at each site ( = 304 with RealTi e CMV and = 153 with LDT CMV). The Alinity m CMV assay had excellent correlation (correlation coefficient ≥0.942) in comparison to the RealTi e CMV or LDT CMV assays. The mean observed bias ranged from -0.03 to 0.34 Log IU/mL. Median onboard turnaround time of Alinity m CMV was less than 3 h. When the CMV assay is run on the Alinity m system, it has the capacity to shorten time to result and, therefore, to therapy.
ISSN:	0095-1137 1098-660X